Overview

Bioavailability and Food Effect of Sodium Valproate Minitablets in Healthy Subjects.

Status:
COMPLETED
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
to evaluate the comparative bioavailability of valproate from Orfiril long 500 mg prolonged release minitablets and Ergenyl chrono 500 mg prolonged-release tablets in healthy, male volunteers under fasting and fed conditions.
Phase:
PHASE1
Details
Lead Sponsor:
Desitin Arzneimittel GmbH
Collaborator:
BioPharma Services Inc.
Treatments:
Valproic Acid